You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BCG

Showing 1 - 25 of 589
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

Not yet recruiting
  • Non-Muscle- Invasive Bladder Cancer
  • Durvalumab
  • BCG
  • (no location specified)
Jul 5, 2023

Trained Immunity, BCG Vaccine, Epigenetics Trial (BCG-Vaccine SSI [Statens Serum Institut]) Danish strain 1331, Placebo)

Not yet recruiting
  • Trained Immunity
  • +2 more
  • BCG-Vaccine SSI [Statens Serum Institut]) Danish strain 1331
  • Placebo
  • (no location specified)
Mar 2, 2023

Alzheimer, Late Onset Trial in Jerusalem (BCG vaccine)

Enrolling by invitation
  • Alzheimer Disease, Late Onset
  • BCG vaccine
  • Jerusalem, Israel
    Department of Neurology, Hadassah medical Center
Oct 5, 2023

Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

Recruiting
  • Non Muscle Invasive Bladder Cancer
  • N803 plus Bacillus Calmette-Guerin (BCG)
  • Honolulu, Hawaii
    Island Urology
Aug 7, 2023

Non-muscular Invasive Bladder Cancer Trial in Changsha (BCG for therapeutic use)

Not yet recruiting
  • Non-muscular Invasive Bladder Cancer
  • BCG for therapeutic use
  • Changsha, China
    Hunan Cancer Hospital
Oct 20, 2023

BCG Vaccination Reaction Trial in Gresik (BCG vial vaccine, BCG ampoule vaccine)

Completed
  • BCG Vaccination Reaction
  • BCG vial vaccine
  • BCG ampoule vaccine
  • Gresik, Jawa Timur, Indonesia
    Puskesmas Cerme
Sep 15, 2022

BCG Vaccination on Infectious and Immune Mediated Diseases

Enrolling by invitation
  • BCG Vaccination Reaction
  • +3 more
  • BCG
  • Placebo vaccine
  • Nijmegen, Gelderland, Netherlands
    Radboud university medical center
Oct 25, 2022

Tuberculosis Trial in Seattle (BCG Vaccine USP, Isoniazid)

Active, not recruiting
  • Tuberculosis
  • Seattle, Washington
    Fred Hutchinson Cancer Center
Dec 9, 2022

Tuberculosis Trial (Intradermal BCG (bacillus calmette-guerin) vaccine AJV)

Not yet recruiting
  • Tuberculosis
  • Intradermal BCG (bacillus calmette-guerin) vaccine AJV
  • (no location specified)
Apr 17, 2023

Non-muscle-invasive Bladder Cancer Trial in Shanghai (BCG combined with Tislelizumab)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • BCG combined with Tislelizumab
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Oct 12, 2022

Urothelial Carcinoma, Bladder Cancer Trial in United States (drug, radiation, biological)

Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Durvalumab (Cohort 1-3)
  • +7 more
  • Phoenix, Arizona
  • +10 more
Jan 11, 2023

Non-muscle-invasive Bladder Cancer Trial (Gemcitabine, Docetaxel, Bacillus Calmette Guerin)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • (no location specified)
Sep 9, 2022

Diabetes, Type 1 Diabetes, Diabetes type1 Trial in Charlestown (Bacillus Calmette-Guérin, Saline Injection)

Recruiting
  • Diabetes Mellitus
  • +3 more
  • Bacillus Calmette-Guérin
  • Saline Injection
  • Charlestown, Massachusetts
    Immunobiology Labs CNY 149
May 10, 2023

Analyzing Urine During BCG Instillation in Bladder Cancer

Not yet recruiting
  • Bladder Cancer
  • urine sample collection
  • Shanghai, Shanghai, China
    Changhai Hospital
Nov 30, 2023

Neutrophils to Lymphocytes Ratio in Predicting Response to BCG

Completed
  • Urinary Bladder Cancer
  • +4 more
  • Neutrophil to lymphocyte ratio
  • Cairo, Egypt
    Ain Shams university
Jul 15, 2023

Death; Neonatal, Death, Infant, Morbidity;Newborn Trial in Bissau (BCG-Denmark, BCG-Bulgaria)

Not yet recruiting
  • Death; Neonatal
  • +4 more
  • BCG-Denmark
  • BCG-Bulgaria
  • Bissau, Guinea-Bissau
    Bandim Health Project
May 26, 2022

Mild Cognitive Impairment, Mild Dementia, Moderate Dementia Trial in Charlestown (Biological/Vaccine: Bacillus Calmette-Guerin

Active, not recruiting
  • Mild Cognitive Impairment
  • +3 more
  • Biological/Vaccine: Bacillus Calmette-Guerin (BCG)
  • Charlestown, Massachusetts
    Alzheimer's Clinical and Translational Research Unit
Feb 2, 2023

Tuberculosis Trial in Chendu (BCG vaccine 1(0.025mg/0.1ml/person), BCG vaccine 2 (0.05mg/0.1ml/person), BCG vaccine

Recruiting
  • Tuberculosis
  • BCG vaccine 1（0.025mg/0.1ml/person）
  • +4 more
  • Chendu, Sichuan, China
    Sichuan Center for Disease Control and Prevention
Sep 1, 2022

Transitional Cell Carcinoma Trial in New York (TICE®-strain BCG, NY-ESO-1 protein, sargramostim)

Completed
Has Results
  • Transitional Cell Carcinoma
  • TICE®-strain BCG
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Severe Illness, Septicaemia, Diarrhoea Trial in Kampala (BCG at birth, Control arm: Delayed BCG)

Recruiting
  • Severe Illness
  • +3 more
  • BCG at birth
  • Control arm: Delayed BCG
  • Kampala, Uganda
    Health Centers in Mukono and Kampala districts
Aug 24, 2022

NMIBC Trial in Beijing (RC48-ADC in Combination with gemcitabine)

Recruiting
  • NMIBC
  • RC48-ADC in Combination with gemcitabine
  • Beijing, Beijing, China
    Peking University First Hosptital
Jul 10, 2023

BCG Vaccination Reaction, Tuberculosis Trial (GC3107, Intradermal BCG SSI inj.)

Completed
  • BCG Vaccination Reaction
  • Tuberculosis
  • GC3107
  • Intradermal BCG SSI inj.
  • Suwon, Korea, Republic of
  • +1 more
Oct 31, 2022

Latent Tuberculosis Trial in Dourados (BCG)

Not yet recruiting
  • Latent Tuberculosis
  • BCG
  • Dourados, Mato Grosso Do Sul, Brazil
    Roberto Oliveira
Sep 13, 2022

Recurrent Bladder Carcinoma, Stage 0a Bladder Urothelial Carcinoma, Stage 0is Bladder Urothelial Carcinoma Trial in Chicago (BCG

Active, not recruiting
Has Results
  • Recurrent Bladder Carcinoma
  • +3 more
  • BCG Solution
  • +3 more
  • Chicago, Illinois
    Northwestern University
Sep 27, 2022

Non-specific Effects of BCG in Under-five Children

Active, not recruiting
  • Immunity, Heterologous
  • BCG
  • Lisboa, Portugal
    Instituto de Higiene e Medicina Tropical
Jul 20, 2022